StockData
ResMed Inc logo

ResMed Inc (RMD) income statement

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Số liệu tài chính tới Q1 năm tài chính 2027, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3011% below fair value
$242.61+4.76 (+2.00%)

Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%

ResMed Inc income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
61.1%
Operating margin
33.0%
Net margin
27.8%
Return on equity, FY2026
24.3%

Financial strength

Current ratio
2.65
Debt to equity
–
Debt to assets
–
Cash to current liabilities
76.3%

Valuation

P/E ratio
22.1
Price to sales
5.95
Price to book
5.74
Dividend yield
0.99%

See a number that looks wrong?